CONMED Corporation (CNMD)
NYSE: CNMD · Real-Time Price · USD
55.19
0.00 (0.00%)
Aug 13, 2025, 4:00 PM - Market open
CONMED Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 1,326 | 1,307 | 1,245 | 1,045 | 1,011 | 862.46 | Upgrade
|
| Revenue Growth (YoY) | 3.94% | 5.00% | 19.06% | 3.45% | 17.18% | -9.70% | Upgrade
|
| Cost of Revenue | 582.83 | 573.98 | 559.9 | 469.73 | 442.6 | 402.16 | Upgrade
|
| Gross Profit | 743.42 | 733.03 | 684.85 | 575.75 | 568.04 | 460.3 | Upgrade
|
| Selling, General & Admin | 540.93 | 519.33 | 504.66 | 441.42 | 414.73 | 374.17 | Upgrade
|
| Research & Development | 53.82 | 54.43 | 52.6 | 47.15 | 43.57 | 40.47 | Upgrade
|
| Operating Expenses | 594.75 | 573.75 | 557.26 | 488.57 | 458.29 | 414.65 | Upgrade
|
| Operating Income | 148.67 | 159.28 | 127.58 | 87.17 | 109.74 | 45.66 | Upgrade
|
| Interest Expense | -34.22 | -37.3 | -39.78 | -28.91 | -35.49 | -44.05 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.42 | - | - | - | -0.05 | - | Upgrade
|
| EBT Excluding Unusual Items | 114.03 | 121.98 | 87.81 | 58.27 | 74.21 | 1.6 | Upgrade
|
| Merger & Restructuring Charges | -0.01 | - | -9.4 | -14.6 | - | - | Upgrade
|
| Other Unusual Items | 23.67 | 41.05 | 2.42 | -114.53 | -1.1 | - | Upgrade
|
| Pretax Income | 137.69 | 163.03 | 80.83 | -70.86 | 73.11 | 1.6 | Upgrade
|
| Income Tax Expense | 27.49 | 30.61 | 16.37 | 9.72 | 10.56 | -7.91 | Upgrade
|
| Net Income | 110.2 | 132.42 | 64.46 | -80.58 | 62.54 | 9.52 | Upgrade
|
| Net Income to Common | 110.2 | 132.42 | 64.46 | -80.58 | 62.54 | 9.52 | Upgrade
|
| Net Income Growth | 11.77% | 105.44% | - | - | 557.16% | -66.75% | Upgrade
|
| Shares Outstanding (Basic) | 31 | 31 | 31 | 30 | 29 | 29 | Upgrade
|
| Shares Outstanding (Diluted) | 31 | 31 | 32 | 30 | 32 | 29 | Upgrade
|
| Shares Change (YoY) | -0.79% | -1.26% | 5.02% | -6.75% | 9.34% | -0.10% | Upgrade
|
| EPS (Basic) | 3.56 | 4.29 | 2.10 | -2.68 | 2.14 | 0.33 | Upgrade
|
| EPS (Diluted) | 3.54 | 4.25 | 2.04 | -2.68 | 1.94 | 0.32 | Upgrade
|
| EPS Growth | 12.82% | 108.33% | - | - | 506.25% | -67.01% | Upgrade
|
| Free Cash Flow | 148.24 | 153.88 | 106.32 | 11.58 | 96.9 | 51.52 | Upgrade
|
| Free Cash Flow Per Share | 4.76 | 4.94 | 3.37 | 0.39 | 3.01 | 1.75 | Upgrade
|
| Dividend Per Share | 0.800 | 0.800 | 0.800 | 0.800 | 0.800 | 0.800 | Upgrade
|
| Gross Margin | 56.05% | 56.08% | 55.02% | 55.07% | 56.21% | 53.37% | Upgrade
|
| Operating Margin | 11.21% | 12.19% | 10.25% | 8.34% | 10.86% | 5.29% | Upgrade
|
| Profit Margin | 8.31% | 10.13% | 5.18% | -7.71% | 6.19% | 1.10% | Upgrade
|
| Free Cash Flow Margin | 11.18% | 11.77% | 8.54% | 1.11% | 9.59% | 5.97% | Upgrade
|
| EBITDA | 220.07 | 229.74 | 197.76 | 154.59 | 177.19 | 113.58 | Upgrade
|
| EBITDA Margin | 16.59% | 17.58% | 15.89% | 14.79% | 17.53% | 13.17% | Upgrade
|
| D&A For EBITDA | 71.4 | 70.46 | 70.17 | 67.42 | 67.44 | 67.93 | Upgrade
|
| EBIT | 148.67 | 159.28 | 127.58 | 87.17 | 109.74 | 45.66 | Upgrade
|
| EBIT Margin | 11.21% | 12.19% | 10.25% | 8.34% | 10.86% | 5.29% | Upgrade
|
| Effective Tax Rate | 19.97% | 18.77% | 20.25% | - | 14.45% | - | Upgrade
|
Updated Jul 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.